Latest filing published 19 Dec 2006 for Ligand Pharmaceuticals INC, €117k.
Insider track record
No signal scores available.
Eric S. Groves: trading record in brief
Eric S. Groves discloses dealings in Ligand Pharmaceuticals Inc to SEC (Form 4). We count 6 filings, every one of them for a trade on 15 December 2006.
Sales make up the whole of the open-market record (3 sales, €429k). Other entries cover 3 option exercises.
The record was last updated on 19 December 2006 with an option exercise (€117k) in Ligand Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Eric S. Groves
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,013 shares@ US$7.63Common StockSEC:0000886163-06-000156:0
- 20,013 shares@ US$11.25Common StockSEC:0000886163-06-000156:1
- 27,476 shares@ US$7.63Common StockSEC:0000886163-06-000156:2
- 27,476 shares@ US$11.22Common StockSEC:0000886163-06-000156:3
- 2,511 shares@ US$7.63Common StockSEC:0000886163-06-000156:4
- 2,511 shares@ US$11.22Common StockSEC:0000886163-06-000156:5
6 of 6 declarations
